ABSTRACT In addition to the inverse association of dietary lycopene with various cancers, studies suggest a role for lycopene in cardiovascular disease (CVD) prevention. We determined whether the intake of lycopene or tomato-based foods is associated with the risk of CVD in a prospective cohort of 39,876 middle-aged and older women initially free of CVD and cancer. Participants completed a food-frequency questionnaire and provided self-reports of coronary risk factors. Dietary lycopene levels were divided into quintiles, and primary lycopene food sources (total tomato-based products, including tomatoes, tomato juice, tomato sauce and pizza) were categorized. During 7.2 y of follow-up, 719 CVD cases (including myocardial infarction, stroke, revascularization and CVD death) occurred. Compared with women in the 1st quintile of lycopene, those in increasing quintiles had multivariate relative risks (RR) of CVD of 1.11, 1.14, 1.15 and 0.90 (P for trend ϭ 0.34). For the consumption of tomato-based products, women consuming 1.5 to Ͻ4, 4 to Ͻ7, 7 to Ͻ10 and Ն10 servings/wk had RR (95% CI) of CVD of 1.02 (0.82-1.26), 1.04 (0.82-1.31), 0.68 (0.49 -0.96) and 0.71 (0.42-1.17) (P for trend ϭ 0.029) compared with women consuming Ͻ1.5 servings/wk. Among lycopene food sources, those in the highest levels of tomato sauce (Ն2 servings/wk) and pizza intake (Ն2 servings/wk), with multivariate RR of 0.76 (0.55-1.05) and 0.66 (0.37-1.18), respectively, had potential reductions in CVD risk. Dietary lycopene was not strongly associated with the risk of CVD. However, the possible inverse associations noted for higher levels of tomato-based products, particularly tomato sauce and pizza, with CVD suggest that dietary lycopene or other phytochemicals consumed as oil-based tomato products confer cardiovascular benefits.
In the United States, Ͼ80% of the intake of dietary lycopene, a carotenoid without provitamin A activity, comes from the consumption of tomato products, including tomatoes, tomato juice and tomato sauces (1) . Numerous studies have demonstrated an inverse association between dietary lycopene and prostate cancer risk (2) . Lycopene cooked and consumed in oil media such as tomato paste, tomato sauce, or pizza appear to be optimal for the efficient absorption of lycopene (3) . Only recently has lycopene been suggested to play a role in preventing cardiovascular disease (CVD) 4 (4) , perhaps through a mechanism involving LDL cholesterol (5) (6) (7) (8) (9) . Data limited to adipose or plasma lycopene in smaller studies suggest an inverse association of lycopene with intima-media thickness, atherosclerosis and CVD (10 -18) . We therefore examined whether dietary lycopene or tomato-based foods were associated with CVD in a large cohort of women.
SUBJECTS AND METHODS
Study population. The Women's Health Study (WHS) is an ongoing clinical trial of low-dose aspirin and vitamin E in the primary prevention of CVD and cancer (19) . The ␤-carotene component of the WHS was terminated in 1996 on the basis of results from other trials (20) . Questionnaires were mailed to Ͼ1.7 million women, of whom 65,169 completed questionnaires and were willing and eligible for the trial. After the successful completion of a run-in phase, 39,876 female U.S. health professionals, who were aged Ն 45 y in 1992, postmenopausal or not intending to become pregnant, and free from prior CVD and cancer (except nonmelanoma skin cancer) were randomized.
At baseline, a 131-item validated semiquantitative food-frequency questionnaire (SFFQ) was completed by 39,310 women, of whom 829 were excluded due to insufficient completion of the SFFQ, or energy intake of either Ͻ2510 or Ն14,644 kJ/d (Ͻ600 or Ն3500 kcal/d). After additionally excluding prerandomization angina or revascular-ization, a study population of 38,445 women remained for analysis; the protocol was approved by the hospital Institutional Review Board.
Lycopene and other covariates. The measurement of lycopene (in mg/d) was based upon food tables maintained by the Harvard School of Public Health, Boston, MA. The validity of lycopene intake measured from the SFFQ was examined in the WHS vs. plasma lycopene levels in a subset of 483 women. The age-adjusted Spearman correlation coefficient was 0.14 for dietary lycopene with plasma lycopene (P ϭ 0.004), and among lycopene food sources only tomato sauce (r ϭ 0.16, P ϭ 0.001) was significant. Other studies indicate high correlations between the SFFQ and dietary records for lycopene food sources (21) , suggesting a valid measurement of SFFQ vs. dietary record lycopene (22) .
Four major lycopene food sources were also considered, including tomatoes, tomato juice, tomato sauce and pizza, without reference to a quantifiable amount of food, but rather a common unit or portion size for each food. Participants selected from nine responses ranging from "Never or less than once per month" to "6ϩ per day."
At baseline, women also provided self-reported age (years), weight and height (BMI, in kg/m 2 ), smoking status (never, former, current), alcohol use (rarely/never, 1-3 drinks/mo, 1-6 drinks/wk, Ն1 drink/ d), exercise (rarely/never, Ͻ1, 1-3, Ն4 times/wk), parental history of myocardial infarction (MI) at Ͻ60 y (no, yes), hypertension (no, yes), diabetes (no, yes), and postmenopausal hormone use (never, former or current). Hypercholesterolemia (no, yes) was defined as any history of treatment for high cholesterol, physician diagnosis or self-reported cholesterol levels of Ն240 mg/dL. In addition to fruit and vegetable intake (apart from tomato-based food products; in servings/d), other dietary nutrients were energy-adjusted using the residual method (23) and included the intake of total fiber (g/d), folate (g/d), nonsupplemental vitamin E (mg/d) and saturated fat (g/d).
Outcome ascertainment. Follow-up consisted of annual followup questionnaires updating health outcomes and risk factors. For each reported CVD endpoint, a consent form was obtained from the participant to request relevant medical records from the hospital or attending physician; nearly all requests were returned. Total CVD included MI, revascularization, stroke and cardiovascular death. Important vascular events, a prespecified endpoint of the WHS, included MI, stroke and cardiovascular death. MI was confirmed using WHO criteria (24). Revascularization procedures were confirmed by hospital records. A stroke was defined as a typical neurological deficit, sudden or rapid in onset, lasting Ͼ24 h. CVD death was documented by convincing evidence of a cardiovascular mechanism from death certificates and medical records. All analyses are based on the first confirmed CVD event. After a median follow-up of 7.2 y, morbidity and mortality follow-up was 98.9% and 99.9% complete.
Data analyses. Lycopene intake was divided into quintiles on the basis of the overall distribution of intake. Participants were first compared according to quintiles of lycopene intake, using mean values or proportions of baseline coronary risk factors. Cox proportional hazards modeled the relative risk (RR) and 95% CI of CVD, important vascular events, MI and stroke with the lowest quintile as the referent. The Ն95th percentile vs. the lowest quintile was also compared. Models were first adjusted for age, total energy intake and randomized treatment assignments, followed by lifestyle and clinical factors, and the final model added dietary factors. Linear trend tests across quintiles of lycopene were tested using the median level for each quintile as an ordinal variable.
Major food sources of lycopene were a priori categorized: tomatoes (one serving comparable to one standard portion size, 1 tomato), none, 1-3 servings/mo, 1-4 servings/wk, Ն5 servings/wk; tomato juice (small glass), none, 1-3 servings/mo, 1 serving/wk, and Ն2 servings/wk; tomato sauce (1/2 cup or 118 mL), none, 1-3 servings/ mo, 1 serving/wk, and Ն2 servings/wk; and pizza (2 slices), none, 1-3 servings/mo, 1 serving/wk, and Ն2 servings/wk. We summed the total number of tomato-based products as done by Giovannucci et al. (25) as Ͻ1.5, 1.5 to Ͻ4, 4 to Ͻ7, 7 to Ͻ10, and Ն10 servings/wk. These analyses included total energy intake (in kJ/d) in each model. The proportional hazards assumption was verified using a Wald test for the interaction of time with each lycopene indicator variable.
RESULTS
The overall mean energy-adjusted lycopene intake was 9197 Ϯ 6442 g/d in a population of women aged 53.9 Ϯ 7.0 y. The major contributors to dietary lycopene intake in this population were tomato sauce (40.5%), tomatoes (39.8%), tomato juice (12.3%), pizza (4.7%) and grapefruit (2.7%). The strongest Spearman correlation coefficients for dietary lycopene were with tomatoes (r ϭ 0.67; P Ͻ 0.001), tomato sauce (r ϭ 0.56; P Ͻ 0.001) and tomato juice (r ϭ 0.35; P Ͻ 0.001). Pizza was weakly correlated (r ϭ 0.05; P Ͻ 0.001) with dietary lycopene. Dietary lycopene was also significantly correlated (all P Ͻ 0.001) with other carotenoids and xanthophylls, including ␣-carotene (Spearman r ϭ 0.18), ␤-carotene (r ϭ 0.30), ␤-cryptoxanthin (r ϭ 0.13) and lutein ϩ zeaxanthin (r ϭ 0.30).
The baseline characteristics of women were first compared according to quintiles of lycopene intake ( Table 1) . Women consuming greater amounts of lycopene were slightly younger. In addition, those in higher quintiles of lycopene intake were more likely to exercise more, less likely to be a current smoker and more likely to be a current postmenopausal hormone user. Higher lycopene intake was also associated with a healthier dietary pattern.
There were 729 total CVD events and 519 important vascular events, including 201 MI and 247 stroke cases, during a median follow-up of 7.2 y. Compared with women in the lowest quintile of dietary lycopene, the age-and treatmentadjusted RR of total CVD in increasing quintiles were 1.00, 1.02, 1.10, 1.02 and 0.90 (P for linear trend ϭ 0.30) ( Table 2 ). The proportional hazards assumption was satisfied (P Ͼ 0.05) for the association between lycopene intake and total CVD. Lycopene intake at or above the 95th percentile, Ն20,215 g/d, had a multivariate RR of 0.77 in the risk of total CVD vs. women in the lowest quintile. The addition of other nutrients (e.g., nonsupplemental ␤-carotene or vitamin C intake, trans fatty acids) or foods (e.g., fatty fish, coffee or tea intake) had no effect on the RR, suggesting that diet did not confound the analyses of lycopene and CVD. Although we included tomato-based foods in our definition of fruit and vegetable intake, there was a high Spearman correlation coefficient (r ϭ 0.99) between fruit and vegetable intake with and without tomato-based foods. Adjustment by either definition had no effect on the RR in all data analyses.
The RR for the association between lycopene intake and important vascular events paralleled the results for total CVD. Women consuming at or above the 95th percentile of the range of lycopene intake vs. the lowest quintile had a RR of 0.66 (0.40 -1.11). Next, the multivariate RR of MI each hovered around one, except for nonsignificant RR of 0.69 and 0.56 in the highest quintile and at or above the 95th percentile, respectively, that drove the linear trend test (P ϭ 0.09). There was also no overall association between lycopene and the risk of stroke.
On average, women consumed 4.32 Ϯ 3.23 servings of tomato-based products per week, of which 2.20 were from tomatoes, 1.14 from tomato sauce, 0.57 from pizza and 0.46 from tomato juice. Women consuming greater amounts of tomato-based products per week had a lower multivariate risk of total CVD (P for linear trend ϭ 0.029), important vascular events (P for linear trend ϭ 0.008), and MI (P for linear trend ϭ 0.033) ( Table 3) . Women consuming Ն7 servings/wk of tomato-based products reduced their CVD risk by ϳ30% vs. those consuming Ͻ1.5 servings/wk. This risk reduction increased substantially for important vascular events, MI and stroke, particularly among women consuming Ն10 servings/wk.
For specific lycopene food sources, the RR of CVD for those consuming tomatoes or tomato juice suggested no clear association with either CVD or important vascular events ( Table  4) . Comparing women consuming Ն2 servings/wk vs. no tomato sauce, the age-and treatment-adjusted RR of total CVD was 0.66 (P for linear trend ϭ 0.008) but with no association among intermediate categories of intake. Multivariate adjustment modestly attenuated the RR of total CVD for women consuming Ն2 servings/wk. Results were stronger for tomato sauce intake and the risk of important vascular events, with a RR of 0.64 (0.43-0.94) comparing women consuming Ն2 servings/wk vs. none (data not shown). Finally, only pizza 2 Energy-adjusted using the residual method (23). 3 Number of events shown in brackets. 4 Adjusted for age, randomized aspirin, randomized vitamin E, and randomized ␤-carotene. 5 Adjusted for the covariates above ϩ BMI, exercise, smoking, postmenopausal hormone use, parental history of myocardial infarction Ͻ60 y, diabetes, hypertension, high cholesterol, and the intake of fruit and vegetables, alcohol, fiber, folate, nonsupplemental vitamin E and saturated fat. The results for more specific cardiovascular endpoints including important vascular events, MI and stroke were generally similar to the results for total CVD for each of the major lycopene food sources. Ischemic stroke accounted for 189 of 247 total stroke cases. Results for ischemic stroke paralleled that for total stroke for all analyses. The RR of ischemic stroke were 1.00 (reference), 1.10, 1.04, 1.27 and 0.87 for increasing quintiles of lycopene, and 1.00 (reference), 0.83, 1.18, 0.49 and 0.24 for increasing categories of tomato-based food products. There was no evidence of effect modification for either randomized aspirin, vitamin E or ␤-carotene treatment, as well as dietary intake of ␤-carotene, vitamin C or vitamin E (all P for interaction Ͼ 0.05) with dietary lycopene for the risk of CVD. Other factors related to oxidation (e.g., smoking, postmenopausal hormones) were also not effect modifiers. Further, we attempted to minimize residual confounding by changes in long-term dietary patterns by excluding women with a baseline history of hypertension, diabetes or hypercholesterolemia. No major differences in the pattern of RR emerged. 
DISCUSSION
In this large prospective study, we found little evidence for an overall association between dietary lycopene intake with the risk of CVD in women. The nonsignificant CVD risk reductions, except for stroke, noted for women with intake at or above the 95th percentile applied only to women consuming large amounts of lycopene at the high end of its distribution. The lack of significance for dietary lycopene may be due to measurement error in assessing lycopene intake from our questionnaire, which did not correlate strongly with plasma lycopene levels. Despite the largely null findings for dietary lycopene, consuming at least 7 servings/wk of tomato-based products was associated with an ϳ30% reduction in the risk of CVD. This finding, in conjunction with the possible inverse associations for higher levels of tomato sauce and pizza intake, parallels the findings observed for more bioavailable lycopene and prostate cancer (2) . Therefore, this study lends support to the notion that either dietary lycopene in bioavailable forms such as tomato sauce or simply tomato-based food products may have a role in CVD prevention.
Previous studies have focused on serum (11,12,17), plasma (13, 15, 16, 18) and adipose tissue (10) levels of lycopene and their associations with atherosclerosis or specific CVD subtypes. Ascherio et al. (26) reported no association between dietary lycopene and stroke in a large cohort of male health professionals. Although most of these studies support an inverse association, given the tremendous interest in other carotenoids often measured in tandem with lycopene, conclusions must be tempered by possible publication bias.
There is an apparent disconnect when comparing blood vs. adipose vs. dietary lycopene, making it difficult to provide mechanistic explanation for previous findings. Data suggest that plasma and adipose carotenoids are not sufficiently correlated to be used interchangeably (27) . In our study, there was a low Spearman correlation between either dietary lycopene (r ϭ 0.14) or tomato sauce (r ϭ 0.16) with plasma lycopene levels, raising questions concerning the biologic mechanism by which dietary lycopene may directly or indirectly be related to CVD (4) . Other studies have reported higher correlations between dietary and plasma lycopene of ϳ0.30 (2, 28) . The weaker correlations between dietary and plasma lycopene may instead reflect differences in more recent, short-term dietary patterns.
The lack of an association between lycopene and CVD in the present study appears to be contradicted by an inverse association found for higher levels of tomato-based products. First, tomato products may lower the risk of CVD through unidentified nutrients other than lycopene. Second, the consumption of tomato products, predominantly as tomatoes and tomato sauce, may be a surrogate for a Mediterranean dietary pattern suggested to have greater cardiovascular benefits (29) . The consumption of tomato-based food sources along with fruit, fresh vegetables and olive oil are common in a Mediterranean dietary pattern and provide a variety of nutrients with potential cardiovascular benefits. Third, there may be both risks and benefits from lycopene food sources resulting in no overall effect with CVD. Pizza may combine both detrimental and beneficial foods, yet it contributed a nominal proportion of lycopene intake, indicating a need for caution in suggesting its consumption for its lycopene content.
Lycopene has strong antioxidant properties relative to other carotenoids (30) and may play a role in the regulation of cholesterol metabolism (6) . Lycopene, as with some other carotenoids, has also been inversely associated with C-reactive protein (31). Short-term supplementation studies have provided dietary lycopene in various forms to investigate its effects on LPL cholesterol, with mixed results (5-9). More short-term intervention studies are warranted to explore specific mechanisms through which dietary lycopene or readily absorbable lycopene food sources may increase plasma lycopene or induce changes in other relevant biochemical markers affecting subsequent CVD risk. Yet, recent null results from major clinical trials investigating various vitamins and antioxidants (32,33) reinforce the importance of building a solid foundation of research on dietary lycopene and tomato-based food products.
Several important methodological considerations must be considered. There is considerable variation in lycopene intake and its food sources across studies, largely due to cultural and temporal patterns in dietary habits. We lacked information on prescribed diets that subjects may have followed; however, lycopene and tomato-based food products would not be expected to be primary target of dietary interventions in women. Inherent misclassification in the single baseline measurement of dietary factors may also have biased our results toward the null, whereas multiple dietary assessments have revealed a stronger magnitude of effect (2) . Misclassification of tomato intake may have also arisen from participants attempting to convert their intake of tomato slices or wedges into the standard portion size of one tomato. Another limitation of epidemiologic studies is that higher lycopene intake may be only a surrogate for other uncontrolled or unidentified lifestyle factors or dietary constituents that are associated with CVD. However, additional control for such measured factors had a nominal effect on the RR. In our analyses of dietary lycopene, the multicolinearity of lycopene with other carotenoids, xanthophylls, and other nutrients and foods may provide alternative explanations to our findings, yet we observed little confounding by diet in this study. Next, these results apply to healthy, middle-aged and older women free of major morbidity and willing to participate in the WHS. More studies should examine dietary lycopene and tomato-based food products in other study populations to ensure consistency. Finally, only 71 of the women died from cardiovascular causes, a small sample for examining the association between lycopene intake and CVD death.
Although we found no association between total dietary lycopene intake and the risk of CVD in women, there was evidence that overall tomato-based product intake may be associated with a reduced risk of CVD. Whether these findings parallel the more thorough epidemiologic evidence for lycopene in prostate cancer prevention, however, remains to be seen.
